285 related articles for article (PubMed ID: 22260323)
41. Burkitt Lymphoma/Leukaemia in Children & Young Adolescents.
O'Rourke E; Malone A; O'Marcaigh A; Storey L; Betts D; McDermott M; Smith OP
Ir Med J; 2020 Jan; 113(1):6. PubMed ID: 32298568
[TBL] [Abstract][Full Text] [Related]
42. Predominance and characteristics of Burkitt lymphoma among children with non-Hodgkin lymphoma in northeastern Brazil.
Sandlund JT; Fonseca T; Leimig T; Verissimo L; Ribeiro R; Lira V; Berard CW; Sixbey J; Crist WM; Mao L; Chen G; Pui CH; Heim M; Pedrosa F
Leukemia; 1997 May; 11(5):743-6. PubMed ID: 9180301
[TBL] [Abstract][Full Text] [Related]
43. The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab.
Forero-Castro M; Robledo C; Lumbreras E; Benito R; Hernández-Sánchez JM; Hernández-Sánchez M; García JL; Corchete-Sánchez LA; Tormo M; Barba P; Menárguez J; Ribera J; Grande C; Escoda L; Olivier C; Carrillo E; García de Coca A; Ribera JM; Hernández-Rivas JM
Br J Haematol; 2016 Feb; 172(3):428-38. PubMed ID: 26567765
[TBL] [Abstract][Full Text] [Related]
44. A rapidly growing lymphoma and tumor lysis syndrome in a toddler.
Green HL; Rytting ME; Cox CS
JAAPA; 2010 Aug; 23(8):30, 32-4. PubMed ID: 20821911
[No Abstract] [Full Text] [Related]
45. Expression of KLF4 is a predictive marker for survival in pediatric Burkitt lymphoma.
Valencia-Hipόlito A; Hernández-Atenógenes M; Vega GG; Maldonado-Valenzuela A; Ramon G; Mayani H; Peña Alonso Y; Martinez-Maza O; Méndez-Tenorio A; Huerta-Yepez S; Bonavida B; Vega MI
Leuk Lymphoma; 2014 Aug; 55(8):1806-14. PubMed ID: 24067139
[TBL] [Abstract][Full Text] [Related]
46. [Clinical analysis of a modified LMB89 Group C regimen in the treatment of pediatric high-risk Burkitt lymphoma].
Zhang M; Jin L; Yang J; Duan YL; Huang S; Zhou CJ; Zhang YH
Zhonghua Xue Ye Xue Za Zhi; 2019 Aug; 40(8):633-638. PubMed ID: 31495128
[No Abstract] [Full Text] [Related]
47. [Oral Burkitt lymphoma in an immunocompetent patient].
Chbicheb S; Hakkou F; El Wady W
Arch Pediatr; 2012 Mar; 19(3):288-92. PubMed ID: 22285713
[TBL] [Abstract][Full Text] [Related]
48. Burkitt lymphoma in adults.
Perkins AS; Friedberg JW
Hematology Am Soc Hematol Educ Program; 2008; ():341-8. PubMed ID: 19074108
[TBL] [Abstract][Full Text] [Related]
49. [Burkitt lymphoma, a diagnostic emergency].
Bredin S; Vergé V; Ribrag V
Rev Prat; 2016 Jan; 66(1):79-82. PubMed ID: 30512408
[TBL] [Abstract][Full Text] [Related]
50. Impact of persistent minimal residual disease post-consolidation therapy in children and adolescents with advanced Burkitt leukaemia: a Children's Oncology Group Pilot Study Report.
Shiramizu B; Goldman S; Smith L; Agsalda-Garcia M; Galardy P; Perkins SL; Frazer JK; Sanger W; Anderson JR; Gross TG; Weinstein H; Harrison L; Barth MJ; Mussolin L; Cairo MS
Br J Haematol; 2015 Aug; 170(3):367-71. PubMed ID: 25858645
[TBL] [Abstract][Full Text] [Related]
51. Case report: acute tumour lysis syndrome.
Chuah CT; Lim LC
Ann Acad Med Singap; 2001 Jan; 30(1):55-7. PubMed ID: 11242627
[TBL] [Abstract][Full Text] [Related]
52. Childhood Burkitt lymphoma: abdominal and pelvic imaging findings.
Biko DM; Anupindi SA; Hernandez A; Kersun L; Bellah R
AJR Am J Roentgenol; 2009 May; 192(5):1304-15. PubMed ID: 19380555
[TBL] [Abstract][Full Text] [Related]
53. Practical recommendations for the management of children with endemic Burkitt lymphoma (BL) in a resource limited setting.
Hesseling P; Israels T; Harif M; Chantada G; Molyneux E;
Pediatr Blood Cancer; 2013 Mar; 60(3):357-62. PubMed ID: 23192950
[TBL] [Abstract][Full Text] [Related]
54. Management of adults with Burkitt lymphoma.
Gastwirt JP; Roschewski M
Clin Adv Hematol Oncol; 2018 Dec; 16(12):812-822. PubMed ID: 30843890
[TBL] [Abstract][Full Text] [Related]
55. Factors influencing survival among Kenyan children diagnosed with endemic Burkitt lymphoma between 2003 and 2011: A historical cohort study.
Buckle G; Maranda L; Skiles J; Ong'echa JM; Foley J; Epstein M; Vik TA; Schroeder A; Lemberger J; Rosmarin A; Remick SC; Bailey JA; Vulule J; Otieno JA; Moormann AM
Int J Cancer; 2016 Sep; 139(6):1231-40. PubMed ID: 27136063
[TBL] [Abstract][Full Text] [Related]
56. Superior outcomes with paediatric protocols in adolescents and young adults with aggressive B-cell non-Hodgkin lymphoma.
Gupta S; Alexander S; Pole JD; Sutradhar R; Crump M; Nagamuthu C; Baxter NN; Nathan PC
Br J Haematol; 2022 Feb; 196(3):743-752. PubMed ID: 34599525
[TBL] [Abstract][Full Text] [Related]
57. [Intestinal lymphoma. A long diagnostic path].
Raab N; Heller T; Kröger J; Freund M; Nizze H; Rolfs A; Liebe S; Löhr M
Med Klin (Munich); 1999 Jun; 94(6):345-52. PubMed ID: 10420727
[TBL] [Abstract][Full Text] [Related]
58. [Primary cardiac Burkitt lymphoma in an African child].
Donegani E; Ambassa JC; Mvondo C; Giamberti A; Ramponi A; Palicelli A; Chelo D
G Ital Cardiol (Rome); 2013 Jun; 14(6):481-4. PubMed ID: 23748548
[TBL] [Abstract][Full Text] [Related]
59. Treatment strategies and risk of central nervous system recurrence in high-grade B-cell and Burkitt lymphoma.
Decker DP; Egan PC; Zayac AS; Treaba DO; Olszewski AJ
Leuk Lymphoma; 2020 Jan; 61(1):198-201. PubMed ID: 31432717
[No Abstract] [Full Text] [Related]
60. Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adults.
Song JY; Venkataraman G; Fedoriw Y; Herrera AF; Siddiqi T; Alikhan MB; Kim YS; Murata-Collins J; Weisenburger DD; Liu X; Duffield AS
Leuk Lymphoma; 2016; 57(4):866-71. PubMed ID: 26450341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
